Share-based Payment Arrangement, Expense of Connect Biopharma Holdings Ltd from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Connect Biopharma Holdings Ltd quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
  • Connect Biopharma Holdings Ltd Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $916,000, a 55% decline year-over-year.
  • Connect Biopharma Holdings Ltd Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $4,210,000.
  • Connect Biopharma Holdings Ltd annual Share-based Payment Arrangement, Expense for 2024 was $6,728,000, a 25% increase from 2023.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Connect Biopharma Holdings Ltd Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,210,000 $916,000 -$1,106,000 -55% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $5,316,000 $951,000 -$1,038,000 -52% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $6,354,000 $942,000 -$374,000 -28% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $6,728,000 $1,401,000 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $2,022,000 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $1,989,000 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 $1,316,000 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1

Connect Biopharma Holdings Ltd Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $6,728,000 +$1,332,000 +25% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $5,396,000 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.